Ingrid E. Wertz

Ingrid E. Wertz

Auto-generated profile, based on publicly available information

Ingrid E. Wertz

Departments of Discovery Oncology, Genentech, 1 DNA Way, South San Francisco, CA, 94080, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2011 in Nature
Verified
Journal Article
Closed access
IWIngrid E. Wertz
Ingrid E. Wertz
SKSaritha Kusam
Saritha Kusam
CLCynthia Lam
Cynthia Lam
TOToru Okamoto
Toru Okamoto
WSWendy Sandoval
Wendy Sandoval
VDVishva M. Dixit
Vishva M. Dixit

11 January 2021 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
PCPeter E. Cockram
Peter E. Cockram
MKMatthias Kist
Matthias Kist
SPSumit Prakash
Sumit Prakash
SCSi-Han Chen
Si-Han Chen
IWIngrid E. Wertz
Ingrid E. Wertz
DVDomagoj Vucic
Domagoj Vucic
The ubiquitin system is complex, multifaceted, and is crucial for the modulation of a vast number of cellular processes. Ubiquitination is tightly regulated at different levels by a range of enzymes including E1s, E2s, and E3s, and an array of DUBs. The UPS directs protein degradation through the proteasome, and regulates a wide array of cellular processes including transcription and epigenetic factors as well as key oncoproteins. Ubiquitination is key to the dynamic regulation of programmed cell death. Notably, the TNF signaling pathway is controlled by competing ubiquitin conjugation and deubiquitination, which governs both proteasomal degradation and signaling complex formation. In the inflammatory response, ubiquitination is capable of both activating and dampening inflammasome activation through the control of either protein stability, complex formation, or, in some cases, directly affecting receptor activity. In this review, we discuss the enzymes and targets in the ubiquitin system that regulate fundamental cellular processes regulating cell death, and inflammation, as well as disease consequences resulting from their dysregulation. Finally, we highlight several pre-clinical and clinical compounds that regulate ubiquitin system enzymes, with the aim of restoring homeostasis and ameliorating diseases.

7 October 2009 in Cold Spring Harbor Perspectives in Biology
Verified
Journal Article
Closed access
PDF file
IWIngrid E. Wertz
Ingrid E. Wertz
VDVishva M. Dixit
Vishva M. Dixit
The NF-κB pathway is a ubiquitous stress response that activates the NF-κB family of transcription factors. Antigen receptors, receptors of the innate immune system, and certain intracellular stressors are potent activators of this pathway. The transcriptional program that is activated is both antiapoptotic and highly proinflammatory. Indeed, any compromise in engagement of the pathway results in immunodeficiency, whereas constitutive activation generates a sustained inflammatory response that may promote malignancy. As such, NF-κB activation is under tight regulation by a number of post-translational modifications, including phosphorylation and ubiquitination. This article attempts to synthesize our current knowledge regarding the regulation of NF-κB signaling by ubiquitination, specifically highlighting the biochemical basis for both positive and negative feedback loops that function in unison to generate coordinated signals that are essential for the viability of metazoan animals.

1 February 2019 in Cell Chemical Biology
Verified
Journal Article
Closed access
IWIngrid E. Wertz
Ingrid E. Wertz
XWXiaojing Wang
Xiaojing Wang

6 November 2009 in Cell Death & Differentiation
Verified
Journal Article
Closed access
IWI E Wertz
I E Wertz
VDV M Dixit
V M Dixit

14 February 2017 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
DHDavid S. Hewings
David S. Hewings
JFJohn A. Flygare
John A. Flygare
MBMatthew Bogyo
Matthew Bogyo
IWIngrid E. Wertz
Ingrid E. Wertz
The reversible post‐translational modification of proteins by ubiquitin and ubiquitin‐like proteins regulates almost all cellular processes, by affecting protein degradation, localization, and complex formation. Deubiquitinases (DUBs) are proteases that remove ubiquitin modifications or cleave ubiquitin chains. Most DUBs are cysteine proteases, which makes them well suited for study by activity‐based probes. These DUB probes report on deubiquitinase activity by reacting covalently with the active site in an enzyme‐catalyzed manner. They have proven to be important tools to study DUB selectivity and proteolytic activity in different settings, to identify novel DUBs, and to characterize deubiquitinase inhibitors. Inspired by the efficacy of activity‐based probes for DUBs, several groups have recently reported probes for the ubiquitin conjugation machinery (E1, E2, and E3 enzymes). Many of these enzymes, while not proteases, also posses active site cysteine residues and can be targeted by covalent probes. In this review, we will discuss how features of the probe (cysteine‐reactive group, recognition element, and reporter tag) affect reactivity and suitability for certain experimental applications. We will also review the diverse applications of the current probes, and discuss the need for new probe types to study emerging aspects of ubiquitin biology.